483 Roundup: FDA Cites Three Firms Over Quality, Other Violations

Drug GMP Report
A A
Arch Pharmalabs received a Form 483 from the FDA listing numerous problems including water quality, documentation and computer system issues.

To View This Article:

Login

Subscribe To Drug GMP Report